Do you have news you would like to share on the NIVAS News Hub?
If you have an RSS feed you wish to share with up please contact us here.
Showing 1-12 of 540 results.
"To explore intravenous drug compatibility information needs of National Health Service (NHS) Injectable Medicines Guide ('Medusa') users. To develop consensus expert recommendations on the intravenous drug compatibility information that Medusa should include” Aguado Lorenzo and Jones (2025).
"Antimicrobial lock therapy can be considered a treatment option for managing CRBSIs, particularly in cases where removal of the implantable catheter is not feasible, allowing for salvage” Aksoy et al (2025).
"Implantable port catheters are vital for cancer treatment, but complications such as infections and mechanical failures pose challenges. Lymphoma and leukemia patients' unique cellular abnormalities may influence these risks. This study aimed to determine whether the underlying disease or varying degrees of cytopenia increase the risk of unplanned early port removal” Lu et al (2025).
"This study revealed significant variation in OPAT practice. Further study is needed to understand the reasons for these differences and whether better alignment of practice could improve patient outcomes, antimicrobial stewardship practice and resource utilization” Wolie et al (2025).
"This study aimed to assess the prevalence, contributing factors, and awareness of post-exposure prophylaxis (PEP) among Estonian nurses” Parm et al (2025)
"The primary end point of any future research on TIVAD maintenance should primarily be focused on the functionality of the TIVAD. The CINAS classification effectively standardizes reporting of TIVAD functionality” Douchy et al (2025).
"We describe the insertion technique of an ultrasound-guided non-tunneled centrally inserted central catheter (CICC) placed in an extremely low-weight and extremely preterm neonate, adapting materials used for placing vascular access devices in the superficial veins of neonates” Rodriguez-Pere et al (2025).
"In an adolescent male with relapsed primary mediastinal lymphoma, complicated by complete SVC obstruction, we report the placement of a port into the right femoral vein by interventional radiology” Lian et al (2025).
" The developed AI model shows strong potential for early CLABSI prediction using routine blood parameters. Future studies should focus on external validation and broader clinical application to enhance early infection prevention, particularly in resource-limited settings” Lahariya et al (2025).
"To compare the contrast enhancement (CE) value, injection rate and contrast material (CM) volume with and without the implanted port system during dynamic hepatic computed tomography (CT) scan” Moriwake et al (2025).
"Patients expressed high satisfaction with low impact on comfort, psychological state and physical well-being. Maintenance experiences varied, highlighting the need for further investigation and a validated comprehensive questionnaire” Goossens et al (2025).
"Repeat CLABSI in the same patient is not uncommon and can contribute significantly to overall inpatient CLABSI rates. Prior CLABSI should be considered a risk factor for future CLABSI” Sotak et al (2025).
